Conditioned medium from Sanhuang Decoction-pretreated MDA-MB-231 cells attenuates endothelial inflammation and barrier dysfunction
Abstract
BackgroundTumor-cell-derived inflammatory signals can alter endothelial activation and barrier integrity in triple-negative breast cancer. Whether pretreating tumor cells with Sanhuang Decoction (SHD) changes the subsequent conditioned-medium (CM)-associated endothelial phenotype remains unclear.MethodsMDA-MB-231 cells were exposed to SHD, washed twice with phosphate-buffered saline, and cultured in fresh drug-free medium before CM collection. Tumor-cell migration, CXCL8 mRNA, and viable donor-cell-normalized CXCL8 secretion were assessed, with selected CCK-8 and CXCL8 validation in MDA-MB-468, BT-549, and Hs578T cells. Human umbilical vein endothelial cells (HUVECs) were exposed to Control-CM, 231-CM, or CM from SHD-pretreated MDA-MB-231 cells and evaluated by RNA sequencing, RT-qPCR, western blotting, immunofluorescence, FITC-dextran permeability, CellTracker-based transendothelial migration, and representative transmission electron microscopy. A direct-SHD HUVEC western blot control and the PI3K agonist 740 Y-P were used to examine direct-exposure effects and pathway participation. Public-data, LC-HRMS/MS profiling, HPLC-DAD emodin marker analysis, network, and enrichment analyses provided study context.ResultsSHD reduced MDA-MB-231 migration, decreased CXCL8 mRNA across the TNBC validation panel, and reduced viable donor-cell-normalized CXCL8 secretion in all four TNBC cell lines, most consistently at 6 mg/mL. In HUVECs, SHD6-CM was associated with opposite-direction changes in a subset of 231-CM-associated transcriptomic features involving cytoskeletal, vascular-wall interaction, PI3K/AKT, and junction-related programs. It reduced VCAM-1, ICAM-1, and PI3K/AKT phosphorylation while increasing ZO-1, VE-cadherin, and Occludin-related readouts. Direct SHD exposure did not reproduce this coordinated HUVEC protein pattern. SHD6-CM was also associated with lower FITC-dextran permeability and fewer CellTracker Green-positive MDA-MB-231 cells crossing the endothelial monolayer. Addition of 740 Y-P attenuated these molecular and functional changes, consistent with partial PI3K/AKT participation.ConclusionCM from SHD-pretreated MDA-MB-231 cells was associated with reduced endothelial inflammatory activation and improved barrier-related readouts in this in vitro model. CXCL8 remains an associated candidate mediator within a multicomponent secretory response, rather than an established sole mediator, and pathway-specific experiments are needed to define the contribution of PI3K/AKT.
Related
- Inhibition of Endothelial Phosphodiesterase 2A Attenuates Post-infarct Inflammation.
- Macrophage‐Derived Glycoprotein Nonmetastatic Melanoma Protein B Attenuates Cardiac Dysfunction by Promoting Vascular Endothelial Growth Factor‐Independent Angiogenesis
- Ellagic Acid Attenuates High-Fat, High-Sucrose Diet-Induced Cardiac Fibrosis by Suppressing AGE–RAGE Signaling, Oxidative Stress, and Inflammation
- Primary cilia disruption reprograms extracellular vesicle signaling in endothelial dysfunction and cardiovascular disease
- Plasma Lipids Associated with Endothelial Dysfunction in Patients with Type 2 Diabetes: A Cross-Sectional Study Using Lipidomic Analysis
BibTeX
@article{hong2026conditioned,
title = {{Conditioned medium from Sanhuang Decoction-pretreated MDA-MB-231 cells attenuates endothelial inflammation and barrier dysfunction}},
author = {Ke Hong and Shuqin Li and Cong Wang and Xinhe Liu and Chang Yao},
journal = {Frontiers in Molecular Biosciences},
year = {2026},
month = nov,
doi = {10.3389/fmolb.2026.1965244},
url = {https://www.frontiersin.org/articles/10.3389/fmolb.2026.1965244},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Conditioned medium from Sanhuang Decoction-pretreated MDA-MB-231 cells attenuates endothelial inflammation and barrier dysfunction
AU - Ke Hong
AU - Shuqin Li
AU - Cong Wang
AU - Xinhe Liu
AU - Chang Yao
PY - 2026
DA - 2026/11/03
JO - Frontiers in Molecular Biosciences
DO - 10.3389/fmolb.2026.1965244
UR - https://www.frontiersin.org/articles/10.3389/fmolb.2026.1965244
AB - BackgroundTumor-cell-derived inflammatory signals can alter endothelial activation and barrier integrity in triple-negative breast cancer. Whether pretreating tumor cells with Sanhuang Decoction (SHD) changes the subsequent conditioned-medium (CM)-associated endothelial phenotype remains unclear.MethodsMDA-MB-231 cells were exposed to SHD, washed twice with phosphate-buffered saline, and cultured in fresh drug-free medium before CM collection. Tumor-cell migration, CXCL8 mRNA, and viable donor-cell-normalized CXCL8 secretion were assessed, with selected CCK-8 and CXCL8 validation in MDA-MB-468, BT-549, and Hs578T cells. Human umbilical vein endothelial cells (HUVECs) were exposed to Control-CM, 231-CM, or CM from SHD-pretreated MDA-MB-231 cells and evaluated by RNA sequencing, RT-qPCR, western blotting, immunofluorescence, FITC-dextran permeability, CellTracker-based transendothelial migration, and representative transmission electron microscopy. A direct-SHD HUVEC western blot control and the PI3K agonist 740 Y-P were used to examine direct-exposure effects and pathway participation. Public-data, LC-HRMS/MS profiling, HPLC-DAD emodin marker analysis, network, and enrichment analyses provided study context.ResultsSHD reduced MDA-MB-231 migration, decreased CXCL8 mRNA across the TNBC validation panel, and reduced viable donor-cell-normalized CXCL8 secretion in all four TNBC cell lines, most consistently at 6 mg/mL. In HUVECs, SHD6-CM was associated with opposite-direction changes in a subset of 231-CM-associated transcriptomic features involving cytoskeletal, vascular-wall interaction, PI3K/AKT, and junction-related programs. It reduced VCAM-1, ICAM-1, and PI3K/AKT phosphorylation while increasing ZO-1, VE-cadherin, and Occludin-related readouts. Direct SHD exposure did not reproduce this coordinated HUVEC protein pattern. SHD6-CM was also associated with lower FITC-dextran permeability and fewer CellTracker Green-positive MDA-MB-231 cells crossing the endothelial monolayer. Addition of 740 Y-P attenuated these molecular and functional changes, consistent with partial PI3K/AKT participation.ConclusionCM from SHD-pretreated MDA-MB-231 cells was associated with reduced endothelial inflammatory activation and improved barrier-related readouts in this in vitro model. CXCL8 remains an associated candidate mediator within a multicomponent secretory response, rather than an established sole mediator, and pathway-specific experiments are needed to define the contribution of PI3K/AKT.
SN - 2296-889X
ER -